{"id":"NCT00544882","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","briefTitle":"A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021","officialTitle":"A Prospective, Multicenter, Randomized, Double-Blind Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With the Oral Contraceptive Regimen DR-1021","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-10-31","primaryCompletion":"2008-03-31","completion":"2008-03-31","firstPosted":"2007-10-16","resultsPosted":"2014-06-10","lastUpdate":"2021-11-18"},"enrollment":61,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Healthy"],"interventions":[{"type":"DRUG","name":"DR-1021","otherNames":["desogestrel/ethinyl estradiol"]},{"type":"DRUG","name":"Mircette®","otherNames":["desogestrel/ethinyl estradiol"]},{"type":"DRUG","name":"Kariva®","otherNames":["desogestrel/ethinyl estradiol"]}],"arms":[{"label":"DR-1021","type":"EXPERIMENTAL"},{"label":"Mircette","type":"ACTIVE_COMPARATOR"}],"summary":"This is a multi-center study to evaluate hormone levels with the oral contraceptive regimen DR-1021.","primaryOutcome":{"measure":"Serum Estradiol Levels by Cycle Day","timeFrame":"Cycle 2, Day 2 (Baseline), and Days 4, 6, 19-20, 23, 24, 25, 27, 28, Cycle 3, Days 2, 4 and 6.","effectByArm":[{"arm":"DR-1021","deltaMin":47,"sd":null},{"arm":"Mircette","deltaMin":51.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.6346"},{"comp":"OG000 vs OG001","p":"0.2757"},{"comp":"OG000 vs OG001","p":"0.1321"},{"comp":"OG000 vs OG001","p":"0.5543"},{"comp":"OG000 vs OG001","p":"0.3940"},{"comp":"OG000 vs OG001","p":"0.7891"},{"comp":"OG000 vs OG001","p":"0.4829"},{"comp":"OG000 vs OG001","p":"0.4526"},{"comp":"OG000 vs OG001","p":"0.2485"},{"comp":"OG000 vs OG001","p":"0.6252"},{"comp":"OG000 vs OG001","p":"0.4003"},{"comp":"OG000 vs OG001","p":"0.8841"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":4,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":28},"commonTop":["Upper respiratory tract infection","Nasal congestion","Nasopharyngitis","Urinary tract infection","Back pain"]}}